View Document Preview and Link Document Date: 2007-04-23 13:44:31 Open Document File Size: 46,08 KB Share Result on Facebook
City Hemodialysis Adequacy / New Haven / / Company BP / GE / / Continent North America / / Country United States / Canada / New Zealand / / / Facility Hospital of St. Raphael / Chapel Street / National Institute of Diabetes / Port FK / / / IndustryTerm phosphate product / cine magnetic resonance imaging / rigorous protocol / / MedicalCondition end-stage renal failure / hypertension / left ventricular hypertrophy / chronic renal failure / Kidney Diseases / ESRD / heart disease / bone disease / invasive breast cancer / kidney failure / End-Stage Renal Disease / inflammation / depression / anemia / cardiac left ventricular hypertrophy / / MedicalTreatment peritoneal dialysis / hemodialysis / kidney transplantation / HRT / hormone replacement therapy / dialysis / Postmenopausal Hormone Replacement Therapy / renal replacement therapy / / Organization National Kidney Foundation / Proc Eur Dial Transplant Assoc / Department of Medicine / National Institute of Diabetes and Digestive / Frequent Hemodialysis Network Study Group Department of Medicine / Hospital of St. Raphael / American Society of Nephrology / Medicare / / Person Ann Intern Med / Alan S. Kliger / / / Position Marshall / / ProvinceOrState New York / / Technology magnetic resonance imaging / rigorous protocol / transplantation / dialysis / / URL www.cjasn.org / http / SocialTag 
Special Feature High-Frequency Hemodialysis: Rationale for Randomized Clinical Trials Alan S. Kliger; for the Frequent Hemodialysis Network Study Group Department of Medicine, Hospital of St. Raphael, New Haven, Connect